granulocyte colony stimulating factor (GCSF)

DRUG3 trials

Sponsors

Barts & The London NHS Trust, Vanderbilt University Medical Center, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Conditions

Diabetes Mellitus, Type 1Dilated CardiomyopathyDystrophic Epidermolysis Bullosa

Phase 2

Bone Marrow Derived Adult Stem Cells for Dilated Cardiomyopathy

CompletedNCT01302171

Barts & The London NHS TrustDilated Cardiomyopathy

Start: 2010-08-31End: 2013-07-31Updated: 2013-11-15

Efficacy of Granulocyte Colony Stimulating Factor (GCSF) In Patients With Dystrophic Epidermolysis Bullosa

CompletedNCT01538862

Vanderbilt University Medical CenterDystrophic Epidermolysis Bullosa

Start: 2012-02-29End: 2014-11-30Updated: 2017-06-23

ATG-GCSF in New Onset Type 1 Diabetes

CompletedNCT02215200

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Diabetes Mellitus, Type 1

Start: 2014-12-31End: 2018-08-31Updated: 2020-03-02

Related Papers

Identifying Promising Immunomodulators for Type 1 Diabetes (T1D) and Islet Transplantation.

2024-12-204 citations

Responders to low-dose ATG induce CD4+ T cell exhaustion in type 1 diabetes

JCI Insight2023-07-1130 citations

DCM Support: Cell Therapy and Circulatory Support for Dilated Cardiomyopathy Patients with Severe Ventricular Impairment

ESC Heart Failure2023-05-153 citations

Antithymocyte globulin therapy for patients with recent-onset type 1 diabetes: 2 year results of a randomised trial.

2016-04-0668 citations